Ring P C, Wan H, Schou C, Kroll Kristensen A, Roepstorff P, Robinson C
Department of Pharmacology and Clinical Pharmacology, St George's Hospital Medical School, Cranmer Terrace, London SW17 0RE, United Kingdom.
Clin Exp Allergy. 2000 Aug;30(8):1085-96. doi: 10.1046/j.1365-2222.2000.00805.x.
Fel d 1, an important allergen from domestic cats, is a significant cause of asthma. In addition to directly promoting IgE synthesis, other biological activities of allergens may contribute to either allergic sensitization or the magnitude of allergic effector responses. For example, allergens that degrade proteins have been suggested to facilitate allergen presentation by increasing parallelular permeability of airways epithelium. However, little information exists to indicate whether Fel d 1 has other activities relevant to allergic responses.
To study whether Fel d 1 is associated with enzyme activity.
Fel d 1 was obtained by a rigorous purification strategy and its identity confirmed by laser desorption mass spectrometry, cleavage and sequencing. The ability of Fel d 1 to degrade gelatin, fibronectin and the artificial substrate N-benzoyl-FVR-p-nitroanilide was studied. The effect of Fel d 1 on the morphology of tight junctions in epithelial cell monolayers was also investigated.
The 18-kDa form of Fel d 1 caused degradation of denatured collagens (gelatin) and cleaved a 20-kDa fragment from the A chain of plasma fibronectin. Catalytic activity was not altered by inhibitors of cysteine peptidases, matrix metallopeptidases or by removal of divalent cations. In contrast, aprotinin and TLCK were inhibitors of Fel d 1. The absence of a serine peptidase catalytic triad in Fel d 1, together with the stoichiometry of the inhibition of TLCK and aprotinin, suggest that their inhibitory action may be due to noncatalytic site interactions. Alternatively, highly purified Fel d 1 may be associated with an active contaminant, although none were found.
These results suggest that Fel d 1 is another example of a domestic allergen which is associated with enzyme activity. It remains to be established whether the activity resides in Fel d 1 itself or in an unresolved, and possibly related, protein.
猫源主要过敏原Fel d 1是哮喘的重要病因。除了直接促进IgE合成外,过敏原的其他生物学活性可能有助于过敏致敏或过敏效应反应的程度。例如,已有人提出能降解蛋白质的过敏原可通过增加气道上皮的细胞旁通透性来促进过敏原呈递。然而,几乎没有信息表明Fel d 1是否具有与过敏反应相关的其他活性。
研究Fel d 1是否与酶活性有关。
通过严格的纯化策略获得Fel d 1,并通过激光解吸质谱、裂解和测序确认其身份。研究了Fel d 1降解明胶、纤连蛋白和人工底物N-苯甲酰基-FVR-对硝基苯胺的能力。还研究了Fel d 1对上皮细胞单层紧密连接形态的影响。
18 kDa形式的Fel d 1可导致变性胶原蛋白(明胶)降解,并从血浆纤连蛋白A链上切割下一个20 kDa的片段。半胱氨酸蛋白酶抑制剂、基质金属蛋白酶抑制剂或去除二价阳离子均未改变催化活性。相反,抑肽酶和胰蛋白酶氯甲基酮是Fel d 1的抑制剂。Fel d 1中不存在丝氨酸蛋白酶催化三联体,以及胰蛋白酶氯甲基酮和抑肽酶抑制的化学计量关系,表明它们的抑制作用可能是由于非催化位点相互作用。或者,高度纯化的Fel d 1可能与一种活性污染物有关,尽管未发现任何污染物。
这些结果表明Fel d 1是另一个与酶活性相关的室内过敏原实例。该活性是存在于Fel d 1本身还是存在于一种未解析的、可能相关的蛋白质中,仍有待确定。